Alamar Biosciences is a rapidly growing company dedicated to enabling scientific discoveries that lead to clinical outcomes benefiting patients. The company focuses on innovative approaches to measure protein biomarkers from liquid samples, facilitating early disease detection. Alamar is committed to advancing the field of proteomics through its proprietary technologies, including the ARGO™ HT System and NULISA™ Platform. The company values collaboration, accountability, and cross-functional teamwork, fostering a culture that encourages breakthrough thinking to solve complex challenges in biomarker discovery and non-invasive disease testing.